Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study
Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significa...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Kim, Mimi Y. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9734 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:214 ; year:2016 ; number:1 ; pages:1081-10814 ; extent:9734 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2015.09.066 |
|---|
| Katalog-ID: |
ELV014511894 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV014511894 | ||
| 003 | DE-627 | ||
| 005 | 20230623114310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2015.09.066 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016020000014.pica |
| 035 | |a (DE-627)ELV014511894 | ||
| 035 | |a (ELSEVIER)S0002-9378(15)01105-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Kim, Mimi Y. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| 264 | 1 | |c 2016 | |
| 300 | |a 9734 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. | ||
| 650 | 7 | |a systemic lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a placental insufficiency |2 Elsevier | |
| 650 | 7 | |a angiogenic factors |2 Elsevier | |
| 650 | 7 | |a preeclampsia |2 Elsevier | |
| 650 | 7 | |a antiphospholipid antibodies |2 Elsevier | |
| 700 | 1 | |a Buyon, Jill P. |4 oth | |
| 700 | 1 | |a Guerra, Marta M. |4 oth | |
| 700 | 1 | |a Rana, Sarosh |4 oth | |
| 700 | 1 | |a Zhang, Dongsheng |4 oth | |
| 700 | 1 | |a Laskin, Carl A. |4 oth | |
| 700 | 1 | |a Petri, Michelle |4 oth | |
| 700 | 1 | |a Lockshin, Michael D. |4 oth | |
| 700 | 1 | |a Sammaritano, Lisa R. |4 oth | |
| 700 | 1 | |a Branch, D. Ware |4 oth | |
| 700 | 1 | |a Porter, T. Flint |4 oth | |
| 700 | 1 | |a Merrill, Joan T. |4 oth | |
| 700 | 1 | |a Stephenson, Mary D. |4 oth | |
| 700 | 1 | |a Gao, Qi |4 oth | |
| 700 | 1 | |a Karumanchi, S. Ananth |4 oth | |
| 700 | 1 | |a Salmon, Jane E. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:214 |g year:2016 |g number:1 |g pages:1081-10814 |g extent:9734 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2015.09.066 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 214 |j 2016 |e 1 |h 1081-10814 |g 9734 |y 214.2016, 1, 108.e1-, (9734 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m y k my myk |
|---|---|
| matchkey_str |
kimmimiybuyonjillpguerramartamranasarosh:2016----:nigncatrmaacerynrgacpeitavreucmsnainsihuuadnihshlpd |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.ajog.2015.09.066 doi GBVA2016020000014.pica (DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Kim, Mimi Y. verfasserin aut Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2016 9734 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier Buyon, Jill P. oth Guerra, Marta M. oth Rana, Sarosh oth Zhang, Dongsheng oth Laskin, Carl A. oth Petri, Michelle oth Lockshin, Michael D. oth Sammaritano, Lisa R. oth Branch, D. Ware oth Porter, T. Flint oth Merrill, Joan T. oth Stephenson, Mary D. oth Gao, Qi oth Karumanchi, S. Ananth oth Salmon, Jane E. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:214 year:2016 number:1 pages:1081-10814 extent:9734 https://doi.org/10.1016/j.ajog.2015.09.066 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 214 2016 1 1081-10814 9734 214.2016, 1, 108.e1-, (9734 S.) 045F 610 |
| spelling |
10.1016/j.ajog.2015.09.066 doi GBVA2016020000014.pica (DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Kim, Mimi Y. verfasserin aut Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2016 9734 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier Buyon, Jill P. oth Guerra, Marta M. oth Rana, Sarosh oth Zhang, Dongsheng oth Laskin, Carl A. oth Petri, Michelle oth Lockshin, Michael D. oth Sammaritano, Lisa R. oth Branch, D. Ware oth Porter, T. Flint oth Merrill, Joan T. oth Stephenson, Mary D. oth Gao, Qi oth Karumanchi, S. Ananth oth Salmon, Jane E. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:214 year:2016 number:1 pages:1081-10814 extent:9734 https://doi.org/10.1016/j.ajog.2015.09.066 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 214 2016 1 1081-10814 9734 214.2016, 1, 108.e1-, (9734 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.ajog.2015.09.066 doi GBVA2016020000014.pica (DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Kim, Mimi Y. verfasserin aut Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2016 9734 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier Buyon, Jill P. oth Guerra, Marta M. oth Rana, Sarosh oth Zhang, Dongsheng oth Laskin, Carl A. oth Petri, Michelle oth Lockshin, Michael D. oth Sammaritano, Lisa R. oth Branch, D. Ware oth Porter, T. Flint oth Merrill, Joan T. oth Stephenson, Mary D. oth Gao, Qi oth Karumanchi, S. Ananth oth Salmon, Jane E. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:214 year:2016 number:1 pages:1081-10814 extent:9734 https://doi.org/10.1016/j.ajog.2015.09.066 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 214 2016 1 1081-10814 9734 214.2016, 1, 108.e1-, (9734 S.) 045F 610 |
| allfieldsGer |
10.1016/j.ajog.2015.09.066 doi GBVA2016020000014.pica (DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Kim, Mimi Y. verfasserin aut Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2016 9734 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier Buyon, Jill P. oth Guerra, Marta M. oth Rana, Sarosh oth Zhang, Dongsheng oth Laskin, Carl A. oth Petri, Michelle oth Lockshin, Michael D. oth Sammaritano, Lisa R. oth Branch, D. Ware oth Porter, T. Flint oth Merrill, Joan T. oth Stephenson, Mary D. oth Gao, Qi oth Karumanchi, S. Ananth oth Salmon, Jane E. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:214 year:2016 number:1 pages:1081-10814 extent:9734 https://doi.org/10.1016/j.ajog.2015.09.066 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 214 2016 1 1081-10814 9734 214.2016, 1, 108.e1-, (9734 S.) 045F 610 |
| allfieldsSound |
10.1016/j.ajog.2015.09.066 doi GBVA2016020000014.pica (DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 570 VZ BIODIV DE-30 fid Kim, Mimi Y. verfasserin aut Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study 2016 9734 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier Buyon, Jill P. oth Guerra, Marta M. oth Rana, Sarosh oth Zhang, Dongsheng oth Laskin, Carl A. oth Petri, Michelle oth Lockshin, Michael D. oth Sammaritano, Lisa R. oth Branch, D. Ware oth Porter, T. Flint oth Merrill, Joan T. oth Stephenson, Mary D. oth Gao, Qi oth Karumanchi, S. Ananth oth Salmon, Jane E. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:214 year:2016 number:1 pages:1081-10814 extent:9734 https://doi.org/10.1016/j.ajog.2015.09.066 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 214 2016 1 1081-10814 9734 214.2016, 1, 108.e1-, (9734 S.) 045F 610 |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:214 year:2016 number:1 pages:1081-10814 extent:9734 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:214 year:2016 number:1 pages:1081-10814 extent:9734 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
systemic lupus erythematosus placental insufficiency angiogenic factors preeclampsia antiphospholipid antibodies |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Kim, Mimi Y. @@aut@@ Buyon, Jill P. @@oth@@ Guerra, Marta M. @@oth@@ Rana, Sarosh @@oth@@ Zhang, Dongsheng @@oth@@ Laskin, Carl A. @@oth@@ Petri, Michelle @@oth@@ Lockshin, Michael D. @@oth@@ Sammaritano, Lisa R. @@oth@@ Branch, D. Ware @@oth@@ Porter, T. Flint @@oth@@ Merrill, Joan T. @@oth@@ Stephenson, Mary D. @@oth@@ Gao, Qi @@oth@@ Karumanchi, S. Ananth @@oth@@ Salmon, Jane E. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3610 |
| id |
ELV014511894 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014511894</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114310.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2015.09.066</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016020000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014511894</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(15)01105-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kim, Mimi Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9734</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">placental insufficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">angiogenic factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">preeclampsia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">antiphospholipid antibodies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buyon, Jill P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guerra, Marta M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Sarosh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Dongsheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laskin, Carl A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petri, Michelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lockshin, Michael D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sammaritano, Lisa R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Branch, D. Ware</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Porter, T. Flint</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Merrill, Joan T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stephenson, Mary D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gao, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karumanchi, S. Ananth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salmon, Jane E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:214</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1081-10814</subfield><subfield code="g">extent:9734</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2015.09.066</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">214</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">1081-10814</subfield><subfield code="g">9734</subfield><subfield code="y">214.2016, 1, 108.e1-, (9734 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Kim, Mimi Y. |
| spellingShingle |
Kim, Mimi Y. ddc 610 ddc 570 fid BIODIV Elsevier systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| authorStr |
Kim, Mimi Y. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 570 VZ BIODIV DE-30 fid Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies Elsevier |
| topic |
ddc 610 ddc 570 fid BIODIV Elsevier systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies |
| topic_unstemmed |
ddc 610 ddc 570 fid BIODIV Elsevier systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies |
| topic_browse |
ddc 610 ddc 570 fid BIODIV Elsevier systemic lupus erythematosus Elsevier placental insufficiency Elsevier angiogenic factors Elsevier preeclampsia Elsevier antiphospholipid antibodies |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j p b jp jpb m m g mm mmg s r sr d z dz c a l ca cal m p mp m d l md mdl l r s lr lrs d w b dw dwb t f p tf tfp j t m jt jtm m d s md mds q g qg s a k sa sak j e s je jes |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| ctrlnum |
(DE-627)ELV014511894 (ELSEVIER)S0002-9378(15)01105-9 |
| title_full |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| author_sort |
Kim, Mimi Y. |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
1081 |
| author_browse |
Kim, Mimi Y. |
| container_volume |
214 |
| physical |
9734 |
| class |
610 610 DE-600 570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Kim, Mimi Y. |
| doi_str_mv |
10.1016/j.ajog.2015.09.066 |
| dewey-full |
610 570 |
| title_sort |
angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the promisse study |
| title_auth |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| abstract |
Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. |
| abstractGer |
Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. |
| abstract_unstemmed |
Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study |
| url |
https://doi.org/10.1016/j.ajog.2015.09.066 |
| remote_bool |
true |
| author2 |
Buyon, Jill P. Guerra, Marta M. Rana, Sarosh Zhang, Dongsheng Laskin, Carl A. Petri, Michelle Lockshin, Michael D. Sammaritano, Lisa R. Branch, D. Ware Porter, T. Flint Merrill, Joan T. Stephenson, Mary D. Gao, Qi Karumanchi, S. Ananth Salmon, Jane E. |
| author2Str |
Buyon, Jill P. Guerra, Marta M. Rana, Sarosh Zhang, Dongsheng Laskin, Carl A. Petri, Michelle Lockshin, Michael D. Sammaritano, Lisa R. Branch, D. Ware Porter, T. Flint Merrill, Joan T. Stephenson, Mary D. Gao, Qi Karumanchi, S. Ananth Salmon, Jane E. |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2015.09.066 |
| up_date |
2024-07-06T21:43:29.368Z |
| _version_ |
1803867609492357120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV014511894</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623114310.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2015.09.066</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016020000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV014511894</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(15)01105-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kim, Mimi Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9734</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over 20% of pregnancies in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibodies (APL) result in an adverse pregnancy outcome (APO) related to abnormal placentation. The ability to identify, early in pregnancy, patients who are destined for poor outcomes would significantly impact care of this high-risk population. In nonautoimmune patients, circulating angiogenic factors are dysregulated in disorders of placentation, such as preeclampsia (PE) and fetal growth restriction.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">placental insufficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">angiogenic factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">preeclampsia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">antiphospholipid antibodies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buyon, Jill P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guerra, Marta M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Sarosh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Dongsheng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laskin, Carl A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petri, Michelle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lockshin, Michael D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sammaritano, Lisa R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Branch, D. Ware</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Porter, T. Flint</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Merrill, Joan T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stephenson, Mary D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gao, Qi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karumanchi, S. Ananth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salmon, Jane E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:214</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:1081-10814</subfield><subfield code="g">extent:9734</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2015.09.066</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">214</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">1081-10814</subfield><subfield code="g">9734</subfield><subfield code="y">214.2016, 1, 108.e1-, (9734 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4022093 |